CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
90 hedge funds and large institutions have $264M invested in Concert Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
34% more funds holding
Funds holding: 67 → 90 (+23)
69% less call options, than puts
Call options by funds: $447K | Put options by funds: $1.46M
Holders
90
Holding in Top 10
3
Calls
$447K
Puts
$1.46M
Top Buyers
| 1 | +$7.62M | |
| 2 | +$6.78M | |
| 3 | +$6.21M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$4.44M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$3.84M |
Top Sellers
| 1 | -$9.95M | |
| 2 | -$8.26M | |
| 3 | -$5M | |
| 4 |
WSA
Wall Street Associates
Lajolla,
California
|
-$4.73M |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$2.09M |